DIURETICS%20Part%201 - PowerPoint PPT Presentation

About This Presentation
Title:

DIURETICS%20Part%201

Description:

DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Department Therapeutic uses: Open angle glaucoma ( IOP by reducing aqueous humor formation via blocking carbonic ... – PowerPoint PPT presentation

Number of Views:269
Avg rating:3.0/5.0
Slides: 47
Provided by: ksumscCom
Category:

less

Transcript and Presenter's Notes

Title: DIURETICS%20Part%201


1
DIURETICSPart 1
  • Prof. Hanan Hagar
  • Pharmacology Department

2
  • Diuretics
  • Are drugs that increase renal excretion of
    sodium and water resulting in increase in urine
    volume.
  • Most diuretics act by interfere with the normal
    sodium handling by the kidney.

3
  • Sites of action for diuretics
  • Target molecules for diuretics are specific
    membrane transport proteins in renal tubular
    epithelial cells (transporters).

4
Classification of diuretics
  • Carbonic Anhydrase Inhibitors
  • Loop Diuretics
  • Thiazides
  • Potassium-Sparing Diuretics
  • Osmotic Diuretics

5
SITES OF ACTION OF DIURETICS
6
kidney
  • Nephron is the unit of the kidney
  • It is classified structurally and functionally
    into different zones
  • Glomerulus
  • Proximal convoluted tubule
  • Descending loop of Henle
  • Ascending loop of Henle
  • Distal convoluted tubule
  • Collecting duct

7
FUNCTION OF THE KIDNEY
  • Kidney is responsible for regulation of fluids
    and electrolytes.
  • Kidney do its function through three processes
  • Glomerular filtration
  • Passive tubular re-absorption
  • Active tubular secretion

8
Regulation of fluids and electrolytes
9
Sites for solutions and water transport along the
nephron
10
  • Glomerular filtration
  • 16-20 of blood entering the kidney is filtered
  • Filtrate contains water, glucose, amino acids,
    sodium bicarbonates, organic solutes and
    electrolytes (sodium, potassium, chloride).

11
  • Proximal convoluted tubules
  • Responsible for re-absorption of
  • all glucose, amino acids
  • organic solutes
  • electrolytes as
  • sodium chloride (NaCl)(66 of Na)
  • sodium bicarbonate (NaHCO3,85)
  • Potassium (K, 66 )

12
  • Proximal convoluted tubule (PCT)
  • HCO3- is reabsorbed by action of enzyme carbonic
    anhydrase (luminal membrane of proximal tubular
    cells).
  • Water (passively following salts to maintain
    osmolarity in tubular fluids (60).
  • PCT is the site of organic acids or bases
    secretory systems

13
carbonic anhydrase
Lumen
Blood
Luminal membrane
Basolateral membrane
14
organic acids or bases secretory systems
  • Organic base secretory system responsible for
    secretion of bases into luminal fluid e.g.
    choline and creatinine
  • Organic acid secretory system responsible for
    secretion of acids into luminal tubular fluid
    e.g. uric acid, NSAIDs, antibiotics and
    diuretics.

15
  • Descending loop of Henle
  • In thin descending loop of Henle
  • water is re-absorbed by osmotic
  • forces in hypertonic medullary
  • interstitium (counter current
  • mechanism)

16
(No Transcript)
17
  • Ascending loop of Henle
  • Is impermeable to water
  • In thick ascending loop of Henle (TAL) is
    responsible for active re-absorption of Na, K and
    Cl (25-30 Na) via transport system in luminal
    membrane called Na/ K / 2Cl- co-transporter
  • TAL is called the diluting segment
  • Ca and Mg enter the interstitial fluid via
    paracellular pathway

18
Ascending loop of Henle
19
  • Distal convoluted tubule (DCT)
  • Is impermeable to water
  • Responsible for active re-absorption of NaCl
    (10) via transport system Na/Cl transporter in
    luminal membrane
  • Ca2 actively reabsorbed via apical Ca channel
    and Na/Ca2 exchanger in basolateral membrane

20
Distal convoluted tubules (DCT)
21
  • Collecting tubule
  • Principal cells are responsible for
    re-absorption of Na (in exchange for K via
    Na/K-ATPase) and water
  • Aldosterone receptors located in the principle
    cells influence Na re-absorption and K secretion
  • Intercalated cells affect H secretion
  • Water re-absorption (anti-diuretic hormone, ADH).

22
COLLECTING TUBULES (CT)
23
COLLECTING TUBULES (CT)
24
Sodium Excretion Regulation
Nephron Segment Filtered Na reabsorbed Na Transporter
Proximal CT 60-70 Na- H transporter
Ascending Loop of Henle 20-30 Na-K-2Cl- transporter
Distal CT 5-10 Na-Cl- transporter
Cortical Collecting Tubules 5 Aldosterone Na channel ADH
25
Site of action of diuretics
Diuretics transporter Function segment
Carbonic anhydrase inhibitors Na/H transporter, Carbonic anhydrase enzyme Re-absorption of 66 Na, K, Ca, Mg, 100 glucose and amino acids 85 NaHCO3 Proximal convoluted tubules
None Acid base transporter Secretion and re-absorption of organic acids and bases Proximal Straight Tubules
Loop diuretics Na/K/2Cl transporter Active reabsorption 25 Na, K, Cl Secondary reabsorption Ca, Mg Thick ascending loop
Thiazide diuretics Na and Cl cotransporter Active tubular reabsorption of 5Na, Cl, Ca Distal convoluted tubules
K-sparing diuretics Na channels K H transporter Na reabsorption K H secretion Collecting tubules
26
  • Diuretics

27
Carbonic Anhydrase Inhibitors
  • Acetazolamide dorzolamide
  • Mechanism of action
  • Inhibits carbonic anhydrase (CA) enzyme in PCT
    thus interferes with NaHCO3 re-absorption and
    causes diuresis.
  • CA is required for reversible reaction, in which
    CO2 H2O ? H2CO3

28
Blood
Lumen
Basolateral membrane
Luminal membrane
29
(No Transcript)
30
Carbonic Anhydrase Inhibitors
31
  • Pharmacological actions
  • ? urinary excretion of bicarbonate, sodium,
    potassium alkaline diuresis
  • Metabolic acidosis.
  • ? urinary phosphate excretion.
  • Weak diuretics.
  • Decreases after several days (self-limiting as
    the blood bicarbonate falls).

32
Carbonic anhydrase inhibitors
33
  • Pharmacokinetics
  • given orally once a day.
  • Onset of action is rapid (30 min).
  • Duration of action (12 h).
  • Excreted by active secretion in proximal
    convoluted tubules forming alkaline urine

34
  • Therapeutic uses
  • Open angle glaucoma (? IOP by reducing aqueous
    humor formation via blocking carbonic anhydrase
    in ciliary body of eye).
  • As prophylactic therapy, in acute mountain
    sickness (to decrease CSF and pH of brain).

35
  • Therapeutic uses
  • Urinary alkalinization to enhance renal excretion
    of acidic substances (uric acid and cysteine in
    cystinuria).
  • Epilepsy (decrease cerebrospinal fluid, CSF).
  • Hyperphosphatemia
  • Metabolic alkalosis

36
  • Adverse effects
  • Hypokalemia (potassium loss).
  • Metabolic acidosis.
  • Renal stone formation (calcium phosphate stones).
  • Hypersensitivity reactions

37
  • Dorzolamide
  • Is a carbonic anhydrase inhibitor
  • Used topically for treatment of increased
    intraocular pressure in open-angle glaucoma.
  • no diuretic or systemic side effects (Why?).

38
LOOP DIURETICSHigh Ceiling diuretics
  • The most efficacious diuretics
  • Efficacy High 25-30 natriuresis
  • Drugs as
  • Furosemide - torsemide
  • Bumetanide - Ethcrynic acid

39
LOOP DIURETICS
  • Mechanism
  • inhibit Na / K / 2 Cl- co-transporter in the
    luminal membrane of the thick ascending loop of
    Henle (TAL).
  • inhibit Ca and Mg re-absorption.

40
Pharmacokinetics
  • Given orally or I. V.
  • Has fast onset of action (suitable for emergency)
  • Have short duration of action.
  • Excreted by active tubular secretion of weak
    acids into urine (compete with uric acid for
    renal secretory system).

41
Ascending loop of Henle
42
Ascending loop of Henle
43
Pharmacological effects
  • ? urinary excretion of Na , K, Ca and Mg
  • ? urine volume
  • ? renal blood flow.

44
  • Uses
  • are drug of choice for emergency situations as
  • Acute pulmonary edema
  • Edema associated with heart failure, nephrotic
    syndrome
  • Acute hyperkalaemia.
  • Acute hypercalcemia

45
Adverse effects
  • Hypokalemia (dietary K supplementation or
    K-sparing diuretics).
  • Metabolic alkalosis.
  • Acute Hypovolemia, postural hypotension

46
Adverse effects
  • Hyponatraemia.
  • Hypomagnesaemia
  • Hyperuricemia (increase gouty attack).
  • Ototoxicity (risk increased if combined with
    aminoglycosides)
  • Allergic reactions
Write a Comment
User Comments (0)
About PowerShow.com